iBio
IBIO
#10296
Rank
NZ$93.35 M
Marketcap
NZ$1.32
Share price
-4.00%
Change (1 day)
-31.57%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -NZ$57.42 Million

According to iBio's latest financial reports the company's current earnings are NZ$0.1 Million. In 2025 the company made an earning of -NZ$44.48 Million a decrease over its 2024 earnings that were of -NZ$25.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$57.42 Million29.09%
2025 -NZ$44.48 Million75.34%
2024 -NZ$25.37 Million-32.2%
2023 -NZ$37.42 Million-50.39%
2022 -NZ$75.41 Million122.23%
2021 -NZ$33.94 Million-12.52%
2020 -NZ$38.79 Million45%
2019 -NZ$26.76 Million-3.71%
2018 -NZ$27.79 Million5.52%
2017 -NZ$26.33 Million18.82%
2016 -NZ$22.16 Million60.34%
2015 -NZ$13.83 Million38.31%
2014 -NZ$10 Million25.01%
2013 -NZ$8 Million
2010 -NZ$22.16 Million360.89%
2009 -NZ$4.81 Million5.77%
2008 -NZ$4.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.89 B-56,845.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-NZ$67.35 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion 489.86%๐Ÿ‡บ๐Ÿ‡ธ USA